Daibiao Xiao

Title: Daibiao Xiao: Innovator in Pharmaceutical Composition for Tumor Treatment

Introduction

Daibiao Xiao is a notable inventor based in Sichuan, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative treatments for tumors. His work is characterized by a focus on pharmaceutical compositions that offer new methods for disease prevention and treatment.

Latest Patents

Daibiao Xiao holds a patent for a pharmaceutical composition aimed at tumor treatment or prevention. This composition includes a 4'-thionucleoside phosphamide derivative or a pharmaceutically acceptable salt, ester, hydrate, solvate, and isomer thereof. The patent also covers any crystalline form or racemate, metabolite, or a combination of these with other drugs. This innovative approach has the potential to enhance therapeutic options for patients suffering from tumors.

Career Highlights

Daibiao Xiao is currently associated with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. His role at the company allows him to leverage his expertise in pharmaceutical development, contributing to advancements in biopharmaceutical research and applications. His dedication to innovation is evident in his patent work and ongoing research efforts.

Collaborations

Daibiao Xiao collaborates with esteemed colleagues, including Lichun Wang and Jingyi Wang. These partnerships foster a collaborative environment that enhances the research and development process, leading to more effective solutions in the biopharmaceutical sector.

Conclusion

Daibiao Xiao's contributions to pharmaceutical innovation, particularly in tumor treatment, highlight his role as a key figure in the biopharmaceutical industry. His work not only advances medical science but also offers hope for improved treatment options for patients.